Piramal Pharma Reports Q2 and H1 FY26 Results, Impacted by CDMO Destocking
Piramal Pharma Limited announced its Q2 and H1 FY26 results, reporting a revenue decrease. Q2 FY26 revenue stood at ₹2,044 crores, a 9% YoY…
Piramal Pharma Reports Q2 and H1 FY26 Results, Impacted by CDMO Destocking
Piramal Pharma Limited announced its Q2 and H1 FY26 results, reporting revenue of ₹2,044 crore for Q2 and ₹3,977 crore for H1. Revenue was…
Piramal Pharma Unaudited Results Reflect $179.3 Million Loss in Q2 2025
Piramal Pharma Limited announced its unaudited standalone and consolidated financial results for Q2 2025. The company reported a consolidated…
Syngene Board Approves Unaudited Financial Results for Q2 2026
Syngene International’s Board of Directors has approved the unaudited financial results for Q2 2026. Consolidated revenue reached ₹9,106…
Piramal Pharma Reports Unaudited Standalone Financial Results for Q2 2026
Piramal Pharma Limited announced its unaudited standalone financial results for the quarter and half-year ended September 30, 2025. The…
Continental Coffee To Acquire 26% Stake in Mukkonda Renewables
Continental Coffee has announced an amendment to its earlier plan to acquire a stake in Mukkonda Renewables Private Limited. Instead of a…
Syngene Q2 FY26 Revenue Rises 2% to ₹911 Crore
Syngene International reports a 2% year-on-year increase in revenue for Q2 FY26, reaching ₹911 Crore. First half revenue grew by 6%. The…
Syngene Board Approves Unaudited Financial Results for Q2 2026
Syngene International’s Board of Directors has approved the unaudited financial results for the quarter and half-year ended September…
Signature Global Sapan Bebarta Resigns as President – Legal
Signature Global announces the resignation of Sapan Bebarta from his position as President – Legal, effective from the close of business…
Sun Pharma Investor Call Audio Recording Available
Sun Pharmaceutical Industries Limited has announced that the audio recording of its investor call held on November 5, 2025, is now available…